Which insulin would be most appropriate for intravenous administration in a patient receiving IV fluids?

Study for the HCC1 Glucose Regulation Test. Engage with flashcards and multiple choice questions, each question is supplemented with hints and detailed explanations. Prepare thoroughly for your exam!

Multiple Choice

Which insulin would be most appropriate for intravenous administration in a patient receiving IV fluids?

Explanation:
When insulin is given through IV fluids, the goal is to have a treatment that acts quickly and can be adjusted rapidly as the patient’s needs change. A rapid-acting insulin analogue has a fast onset and short duration, so its effect can be titrated precisely to control blood glucose during ongoing IV therapy without lingering too long after stopping the infusion. Insulin lispro, as a rapid-acting option, provides this quick, adjustable control, making it appropriate for IV use in settings where the insulin effect needs to respond promptly to dose changes. In contrast, intermediate-acting insulin (NPH) has a slower onset and longer duration, and long-acting insulins (detemir, glargine) are designed for basal, ongoing coverage rather than rapid IV titration. The key idea is matching the insulin’s onset and duration to the needs of an IV infusion, where quick, adjustable control is essential.

When insulin is given through IV fluids, the goal is to have a treatment that acts quickly and can be adjusted rapidly as the patient’s needs change. A rapid-acting insulin analogue has a fast onset and short duration, so its effect can be titrated precisely to control blood glucose during ongoing IV therapy without lingering too long after stopping the infusion. Insulin lispro, as a rapid-acting option, provides this quick, adjustable control, making it appropriate for IV use in settings where the insulin effect needs to respond promptly to dose changes. In contrast, intermediate-acting insulin (NPH) has a slower onset and longer duration, and long-acting insulins (detemir, glargine) are designed for basal, ongoing coverage rather than rapid IV titration. The key idea is matching the insulin’s onset and duration to the needs of an IV infusion, where quick, adjustable control is essential.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy